269 related articles for article (PubMed ID: 19368899)
1. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
Vinogradov S; Fisher M; Holland C; Shelly W; Wolkowitz O; Mellon SH
Biol Psychiatry; 2009 Sep; 66(6):549-53. PubMed ID: 19368899
[TBL] [Abstract][Full Text] [Related]
2. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
[TBL] [Abstract][Full Text] [Related]
3. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia.
Fisher M; Loewy R; Carter C; Lee A; Ragland JD; Niendam T; Schlosser D; Pham L; Miskovich T; Vinogradov S
Schizophr Bull; 2015 Jan; 41(1):250-8. PubMed ID: 24444862
[TBL] [Abstract][Full Text] [Related]
4. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
5. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
[TBL] [Abstract][Full Text] [Related]
6. Neuroscience-informed Auditory Training in Schizophrenia: A Final Report of the Effects on Cognition and Serum Brain-Derived Neurotrophic Factor.
Fisher M; Mellon SH; Wolkowitz O; Vinogradov S
Schizophr Res Cogn; 2016 Mar; 3():1-7. PubMed ID: 26705516
[TBL] [Abstract][Full Text] [Related]
7. Combining computerized social cognitive training with neuroplasticity-based auditory training in schizophrenia.
Sacks S; Fisher M; Garrett C; Alexander P; Holland C; Rose D; Hooker C; Vinogradov S
Clin Schizophr Relat Psychoses; 2013; 7(2):78-86A. PubMed ID: 23367504
[TBL] [Abstract][Full Text] [Related]
8. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
10. Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia.
Subramaniam K; Luks TL; Fisher M; Simpson GV; Nagarajan S; Vinogradov S
Neuron; 2012 Feb; 73(4):842-53. PubMed ID: 22365555
[TBL] [Abstract][Full Text] [Related]
11. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
[TBL] [Abstract][Full Text] [Related]
13. BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial.
Penadés R; López-Vílchez I; Catalán R; Arias B; González-Rodríguez A; García-Rizo C; Masana G; Ruíz V; Mezquida G; Bernardo M
Schizophr Res; 2018 Jul; 197():458-464. PubMed ID: 29274733
[TBL] [Abstract][Full Text] [Related]
14. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
15. Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
Sun ZL; Liu J; Guo W; Jiang T; Ma C; Li WB; Tang YL; Ling SH
Psychiatry Res; 2016 Oct; 244():370-5. PubMed ID: 27525826
[TBL] [Abstract][Full Text] [Related]
16. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial.
Kimhy D; Vakhrusheva J; Bartels MN; Armstrong HF; Ballon JS; Khan S; Chang RW; Hansen MC; Ayanruoh L; Lister A; Castrén E; Smith EE; Sloan RP
Schizophr Bull; 2015 Jul; 41(4):859-68. PubMed ID: 25805886
[TBL] [Abstract][Full Text] [Related]
19. Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later.
Fisher M; Holland C; Subramaniam K; Vinogradov S
Schizophr Bull; 2010 Jul; 36(4):869-79. PubMed ID: 19269924
[TBL] [Abstract][Full Text] [Related]
20. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
